How can the impact of health technology assessments be enhanced

Published on Jan 1, 2008
Corinna Sorenson14
Estimated H-index: 14
Michael Drummond72
Estimated H-index: 72
+ 1 AuthorsReinhard Busse44
Estimated H-index: 44
  • References (37)
  • Citations (23)
📖 Papers frequently viewed together
5 Citations
1 Author (Rainer Fehr)
25 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Corinna SorensonH-Index: 14
#2Michael Drummond (Ebor: University of York)H-Index: 72
Last. Alistair McGuireH-Index: 45
view all 4 authors...
13 Citations
#1Corinna SorensonH-Index: 14
#2Michael DrummondH-Index: 72
Last. Panos KanavosH-Index: 34
view all 3 authors...
This book provides a detailed review of the role of health technology assessment (HTA) in the European Union. It examines both method and process in the prioritization and financing of modern health care, and presents extensive case studies from Sweden, the Netherlands, Finland, France, Germany and the United Kingdom.
104 Citations
#1Jonathan Shepherd (University of Southampton)H-Index: 47
#2Jackie Briggs (University of Southampton)H-Index: 1
Last. Martin Ashton-KeyH-Index: 1
view all 6 authors...
This is one of the few published examples of innovative methodology to identify and prioritize topics for HTA. Specialty mapping can make a positive contribution to the policy agenda, with several research and policy gaps being fed into existing prioritization channels. Adequate time, resources, and capacity is required particularly in engaging stakeholders and developing a care pathway. Implementation of specialty mapping in other topic areas with on-going evaluation is recommended.
5 CitationsSource
#1Francesco MartelliH-Index: 17
#2Giuseppe La Torre (UCSC: Catholic University of the Sacred Heart)H-Index: 40
Last. Walter Ricciardi (UCSC: Catholic University of the Sacred Heart)H-Index: 32
view all 8 authors...
Objectives: The aim of the study is to make an international comparison of Health Technology Assessment (HTA) Agencies, to show their similarities and differences. Methods: An e-mail questionnaire was sent to thirty HTA agencies internationally. Questions related to the structure of the agency, the relationship with health-related institutions, the prescriptiveness of the decisions taken, the main core and the modalities to spread the assessment, and the type of funding. Results: Twenty-four HTA...
24 CitationsSource
#1John Hutton (Ebor: University of York)H-Index: 29
#2Paul Trueman (Ebor: University of York)H-Index: 16
Last. Christopher Henshall (Ebor: University of York)H-Index: 2
view all 3 authors...
The application of conditionality to coverage decisions for healthcare technologies is increasing. Coverage with Evidence Development (CED) represents a specific approach to coverage for promising technologies for which the evidence remains uncertain. CED demands that additional evidence is generated to address the sources of uncertainty and secure ongoing coverage. This study explores the conceptual and policy issues relating to CED and discusses issues involved in operationalizing CED in pract...
111 CitationsSource
#1Kieran Murphy (University of Birmingham)H-Index: 1
#2Claire Packer (University of Birmingham)H-Index: 12
Last. Sue Simpson (University of Birmingham)H-Index: 13
view all 4 authors...
Objectives: The aim of this study was to define an effective early warning system, to identify and rank the characteristics of an effective early warning system for emerging health technologies, and to evaluate current early warning systems against these characteristics. Methods: An iterative Delphi-type process with the thirteen members of the International Information Network on New and Changing Health Technologies (EuroScan). We synthesized key characteristics that network members had graded....
30 CitationsSource
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Christopher Jones (Johns Hopkins University)H-Index: 3
Background: In conjunction with other important movements in contemporary medicine, including evidence-based medicine (EBM), health technology assessment (HTA) has promoted a culture of critical evaluation. Despite this impact, institutional and methodological challenges are associated with HTA. For example, only in recent years has HTA attempted an open dialogue with patients; however, this is normally done by giving them a “seat” at the HTA decision-making table, rather than by more scientific...
112 CitationsSource
#1Lars Holger Ehlers (Aarhus University Hospital)H-Index: 18
#2Malene Vestergaard (National Board of Health)H-Index: 1
Last. Mette Kjølby (Aarhus University Hospital)H-Index: 6
view all 9 authors...
Objectives: The purpose of this project was to evaluate local decision support tools used in the Danish hospital sector from a theoretical and an empirical point of view. Methods: The use of local decision support was evaluated through questionnaires sent to all county health directors, all hospital managers, and all heads of clinical departments in cardiology, orthopedic surgery, and intensive care. In addition, respondents were asked to submit whatever decision support tools they were using (i...
54 CitationsSource
#1Karla Douw (University of Southern Denmark)H-Index: 6
#2Hindrik Vondeling (University of Southern Denmark)H-Index: 14
Objectives: Uncertainty is pervasive in decision making on new health technologies; therefore, some countries have put systems in place to support decision makers with timely information. An important, but as yet undocumented, determinant of the potential value for decision making of these so-called horizon scanning systems (HSSs) is how the most significant health technologies are selected. Methods: All thirteen member organizations of EuroScan, a collaborative network for HSSs, were surveyed a...
50 CitationsSource
#1John Hutton (Ebor: University of York)H-Index: 29
#2C. McGrath (Pfizer)H-Index: 5
Last. Christopher Henshall (Ebor: University of York)H-Index: 2
view all 6 authors...
Objectives: Australia, Canada, and many European countries now use various forms of health technology assessment (HTA) in decision making regarding the reimbursement of drugs and other health technologies. To achieve a better understanding of the potential for use of HTA in this context, an analytical framework was developed to describe and classify existing fourth hurdle systems. Methods: Based on a review of published literature, and official documentation, the key aspects of a fourth hurdle s...
87 CitationsSource
Cited By23
#1Hussain Abdulrahman Al-Omar (KSU: King Saud University)H-Index: 3
Last. Ibrahim A. Aljuffali (KSU: King Saud University)H-Index: 15
view all 3 authors...
ABSTRACTObjectives: Saudi Arabia is undergoing a massive health-care transformation to fulfill its new, national ‘Vision 2030.’ To align with this objective, Saudi Arabia is establishing a new, ind...
#1Mónica Duarte Oliveira (University of Lisbon)H-Index: 15
#2Inês Mataloto (University of Lisbon)
Last. Panos Kanavos (LSE: London School of Economics and Political Science)H-Index: 34
view all 3 authors...
Background Multi-criteria decision analysis (MCDA) concepts, models and tools have been used increasingly in health technology assessment (HTA), with several studies pointing out practical and theoretical issues related to its use. This study provides a critical review of published studies on MCDA in the context of HTA by assessing their methodological quality and summarising methodological challenges.
#2Michal Stanak (University of Vienna)H-Index: 2
Last. Sarah WolfH-Index: 1
view all 3 authors...
Background Given limited resources compared to the demand for them, spending resources efficiently is important. Key methods applied for supporting efficient resource allocation are health economic evaluations.
Objectives: The aim of this study was to identify good practice principles for health technology assessment (HTA) that are the most relevant and of highest priority for application in Latin America and to identify potential barriers to their implementation in the region. Methods: HTA good practice principles proposed at the international level were identified and then explored during a deliberative process in a forum of assessors, funders, and product manufacturers. Results: Forty-two representa...
3 CitationsSource
#1Sabine VoglerH-Index: 1
Preissetzung und Erstattung fur neue patentgeschutzte Arzneimittel in Deutschland unterscheiden sich in einigen wenigen, aber relevanten Punkten von anderen europaischen Landern. In Deutschland kann ein Arzneimittel nach Vorliegen der Zulassung unverzuglich auf den Markt gebracht werden; es ist im ersten Jahr grundsatzlich erstattungsfahig und kann zu einem vom pharmazeutischen Unternehmer bestimmten Preis angeboten werden. Dies ist in keinem anderen europaischen Land in dieser Form moglich. Abg...
1 CitationsSource
#2Nattha TritasavitH-Index: 6
Last. Sripen TantivessH-Index: 18
view all 5 authors...
5 CitationsSource
There is a lack of evidence concerning the link between HTA and outcomes in terms of health improvements. This work proposes a framework for assessing the impact of HTA. This impact assessment is a necessary step in then better understanding the value for money of HTA bodies. We emphasis that this is still a work in progress. iDSI has developed a theory of change-based framework in order to evaluate the impact the iDSI has on institutional strengthening – leading to ‘better decisions’ for ‘bette...
#1P. Poulin (U of C: University of Calgary)H-Index: 11
#2Lea Austen (U of C: University of Calgary)
Last. Trevor Schuler (U of A: University of Alberta)H-Index: 1
view all 4 authors...
The Surgery Strategic Clinical Network (SSCN) within Alberta Health Services (AHS) has implemented an “Evidence Decision Support Program (EDSP)” to help identify, prioritize, evaluate, and recommend new technologies for possible introduction into the health-care system, with specific focus on the hospital setting. The EDSP does not conduct health technology assessment (HTA) reports, but rather provides a model to make evidence-informed decision about whether and under what conditions innovations...
#1Antoine PiauH-Index: 8
#2Yoann CharlonH-Index: 3
Last. Fati NourhashemiH-Index: 27
view all 5 authors...
Background: Older individuals frequently experience reversible “frailty syndrome,”, increasing incidence of disability. Although physical exercise interventions may delay functional decline, there are difficulties in implementing them and performing seamless follow-up at home. Very few technological solutions attempt to address this challenge and improve individual participation. Objective: Our objectives are to (1) develop a technological solution designed to support active aging of frail older...
5 CitationsSource
#1Ricard Meneu (UPF: Pompeu Fabra University)H-Index: 8
The first published guidance from the National Institute for Clinical Excellence (NICE) started with the words “the practice of prophylactic removal of pathology-free impacted third molars should be discontinued in the NHS” [1]. Since then, NICE has produced almost 300 more technological appraisals of medical devices, tests, surgical procedures and, mainly, drugs. Maybe it is time to assess whether health technology assessment (HTA) has reached its coming of age or is merely an impacted molar in...
1 CitationsSource